185 related articles for article (PubMed ID: 36077689)
41. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma.
Zumbach K; Hoffmann M; Kahn T; Bosch F; Gottschlich S; Görögh T; Rudert H; Pawlita M
Int J Cancer; 2000 Mar; 85(6):815-8. PubMed ID: 10709102
[TBL] [Abstract][Full Text] [Related]
42. Effects of Methylation Status of CpG Sites within the HPV16 Long Control Region on HPV16-Positive Head and Neck Cancer Cells.
Zhang C; Deng Z; Pan X; Uehara T; Suzuki M; Xie M
PLoS One; 2015; 10(10):e0141245. PubMed ID: 26509736
[TBL] [Abstract][Full Text] [Related]
43. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
44. Expression and molecular regulation of non-coding RNAs in HPV-positive head and neck squamous cell carcinoma.
Guo D; Yang M; Li S; Zhu W; Chen M; Pan J; Long D; Liu Z; Zhang C
Front Oncol; 2023; 13():1122982. PubMed ID: 37064141
[TBL] [Abstract][Full Text] [Related]
45. DNA Methylation and HPV-Associated Head and Neck Cancer.
Nakagawa T; Kurokawa T; Mima M; Imamoto S; Mizokami H; Kondo S; Okamoto Y; Misawa K; Hanazawa T; Kaneda A
Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33920277
[TBL] [Abstract][Full Text] [Related]
46. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
47. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
48. Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.
Bao Y; Gabrielpillai J; Dietrich J; Zarbl R; Strieth S; Schröck F; Dietrich D
Clin Epigenetics; 2021 Dec; 13(1):228. PubMed ID: 34933671
[TBL] [Abstract][Full Text] [Related]
49. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.
van Houten VM; Snijders PJ; van den Brekel MW; Kummer JA; Meijer CJ; van Leeuwen B; Denkers F; Smeele LE; Snow GB; Brakenhoff RH
Int J Cancer; 2001 Jul; 93(2):232-5. PubMed ID: 11410871
[TBL] [Abstract][Full Text] [Related]
50. LINC00460 Promotes Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Head and Neck Squamous Cell Carcinoma via miR-320a/BGN Axis.
Yang Y; Wang R; Feng L; Ma H; Fang J
Onco Targets Ther; 2021; 14():2279-2291. PubMed ID: 33833526
[TBL] [Abstract][Full Text] [Related]
51. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas.
Bennett KL; Lee W; Lamarre E; Zhang X; Seth R; Scharpf J; Hunt J; Eng C
Genes Chromosomes Cancer; 2010 Apr; 49(4):319-26. PubMed ID: 20029986
[TBL] [Abstract][Full Text] [Related]
52. Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
Cheng H; Fertig EJ; Ozawa H; Hatakeyama H; Howard JD; Perez J; Considine M; Thakar M; Ranaweera R; Krigsfeld G; Chung CH
Cancer Biol Ther; 2015; 16(8):1252-8. PubMed ID: 26046389
[TBL] [Abstract][Full Text] [Related]
53.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
54. HPV Enhances HNSCC Chemosensitization by Inhibiting SERPINB3 Expression to Disrupt the Fanconi Anemia Pathway.
Huang Z; Chen Y; Chen R; Zhou B; Wang Y; Hong L; Wang Y; Wang J; Xu X; Huang Z; Chen W
Adv Sci (Weinh); 2022 Nov; 10(1):e2202437. PubMed ID: 36382555
[TBL] [Abstract][Full Text] [Related]
55. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
56. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.
Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q
Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806
[TBL] [Abstract][Full Text] [Related]
57. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
[TBL] [Abstract][Full Text] [Related]
58. Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.
Fontan CT; Das D; Bristol ML; James CD; Wang X; Lohner H; Atfi A; Morgan IM
mSphere; 2020 Dec; 5(6):. PubMed ID: 33298572
[TBL] [Abstract][Full Text] [Related]
59. 4NQO enhances differential activation of DNA repair proteins in HPV positive and HPV negative HNSCC cells.
Shishodia G; Toledo RRG; Rong X; Zimmerman E; Xiao AY; Harrison L; Nathan CO
Oral Oncol; 2021 Nov; 122():105578. PubMed ID: 34695758
[TBL] [Abstract][Full Text] [Related]
60. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.
Xie X; Piao L; Bullock BN; Smith A; Su T; Zhang M; Teknos TN; Arora PS; Pan Q
Oncogene; 2014 Feb; 33(8):1037-46. PubMed ID: 23474763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
